Vyvanse 30 MG capsule 100S
Ended Awarded
- Contract number
- SPE2DR26FQP6B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,361
Award facts
- Contract value 100% obligated
- $10,360.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,360.56 to AmerisourceBergen Drug Corp for 100 capsules of Vyvanse 30 mg, a prescription stimulant medication commonly used to treat attention deficit hyperactivity disorder and narcolepsy. The award, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, was made on a firm fixed-price basis with no set-aside designation, indicating competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026. This prime contract enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, serving customers including the Defense Health Agency and U.S. Coast Guard. The company's federal contract portfolio demonstrates its capability to fulfill diverse pharmaceutical requirements through open competition, ranging from specialty medications and brand-name drugs to vaccines and medical supplies across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FQP6B?
SPE2DR26FQP6B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26FQP6B worth?
The government has obligated $10,361 on SPE2DR26FQP6B.
Is contract SPE2DR26FQP6B an order under another contract?
Yes. SPE2DR26FQP6B is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQP6B competed?
The extent of competition for SPE2DR26FQP6B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award